Improving Atopic Dermatitis Patient Outcomes Through the Electronic Medical Record

Wake Forest University Health Sciences

Our study aims to fill the gaps in standardized clinical assessment of atopic dermatitis (AD), adherence, and the quality of care AD patients receive. Our study proposes implementation of an atopic dermatitis assessment tool within the electronic medical record system (EMR) that can be utilized by dermatologists and non-dermatology health care providers to quickly document the severity of the patient’s AD and its impact. The template would guide the provider to create an individualized eczema treatment plan, providing a patient and/or their caregiver with written information structured to maximize adherence. The EMR patient portal would also be utilized as a way to communicate with patients shortly after their clinic visit to assess the effectiveness of their AD treatment regimen, providing the accountability that encourages patients to fill their prescriptions and start on treatment and an advance over interventions that provide only education1.  Our information technology team has the skills to implement these approaches via our EMR.  A randomized controlled trial is proposed to generate evidence to support the value of the intervention.  Intervention and control groups would be compared to assess adherence to AD treatment guidelines and for objective clinical disease improvement. Physicians and subjects in the intervention group would be surveyed to receive feedback on the EMR assessment tool. Demonstration of the feasibility of this approach will provide us a foundation for further studies to optimize this intervention and the care of patients of AD.

Full ProposalInterim ReportsFinal Report
Approval Date:
November 2017
Amount Awarded:
Start Date:
End Date:
In Progress
Quality Improvements in AD